Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Odawara

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Endocrine Journal|March 10, 2022
Subacute thyroiditis with liver dysfunction following coronavirus disease 2019 (COVID-19) vaccination: report of two cases and a literature reviewMiyako Kishimoto, Takuya Ishikawa, Masato Odawara
Endocrine Journal|February 2, 2012
Administration of highly purified eicosapentaenoic acid to statin-treated diabetic patients further improves vascular functionJunko Sasaki, Takashi Miwa, Masato Odawara
Scientific Reports|November 12, 2025
Risk factors for gestational diabetes mellitus and postpartum glucose intolerance: a retrospective study from a hospital specializing in infertility treatmentMiyako Kishimoto, Shinichi Tamaru, Masato Odawara
Diabetology & Metabolic Syndrome|February 18, 2014
Incidence and predictors of hypoglycemia in Japanese patients with type 2 diabetes treated by insulin glargine and oral antidiabetic drugs in real-life: ALOHA post-marketing surveillance study sub-analysisMasato Odawara, Takashi Kadowaki, Yusuke Naito
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 27, 2018
Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web SurveyHiroki Murayama, Kota Imai, Masato Odawara
Diabetes Technology & Therapeutics|April 25, 2012
Dosing of insulin glargine to achieve the treatment target in Japanese type 2 diabetes on a basal supported oral therapy regimen in real life: ALOHA study subanalysisMasato Odawara, Tetsuya Ohtani, Takashi Kadowaki
Expert Opinion on Therapeutic Targets|October 13, 2015
Genes associated with diabetes: potential for novel therapeutic targets?Kazuo Hara, Takashi Kadowaki, Masato Odawara
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 8, 2014
Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes MellitusMasato Odawara, Izumi Hamada, Manabu Suzuki
Current Medical Research and Opinion|July 6, 2007
The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular riskJohn E Gerich, Masato Odawara, Yasuo Terauchi
Plos One|August 8, 2012
Potential formula for the calculation of starting and incremental insulin glargine doses: ALOHA subanalysisTakashi Kadowaki, Tetsuya Ohtani, Yusuke Naito, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Endocrine Journal|March 10, 2022
Subacute thyroiditis with liver dysfunction following coronavirus disease 2019 (COVID-19) vaccination: report of two cases and a literature reviewMiyako Kishimoto, Takuya Ishikawa, Masato Odawara
Endocrine Journal|February 2, 2012
Administration of highly purified eicosapentaenoic acid to statin-treated diabetic patients further improves vascular functionJunko Sasaki, Takashi Miwa, Masato Odawara
Scientific Reports|November 12, 2025
Risk factors for gestational diabetes mellitus and postpartum glucose intolerance: a retrospective study from a hospital specializing in infertility treatmentMiyako Kishimoto, Shinichi Tamaru, Masato Odawara
Diabetology & Metabolic Syndrome|February 18, 2014
Incidence and predictors of hypoglycemia in Japanese patients with type 2 diabetes treated by insulin glargine and oral antidiabetic drugs in real-life: ALOHA post-marketing surveillance study sub-analysisMasato Odawara, Takashi Kadowaki, Yusuke Naito
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 27, 2018
Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web SurveyHiroki Murayama, Kota Imai, Masato Odawara
Diabetes Technology & Therapeutics|April 25, 2012
Dosing of insulin glargine to achieve the treatment target in Japanese type 2 diabetes on a basal supported oral therapy regimen in real life: ALOHA study subanalysisMasato Odawara, Tetsuya Ohtani, Takashi Kadowaki
Expert Opinion on Therapeutic Targets|October 13, 2015
Genes associated with diabetes: potential for novel therapeutic targets?Kazuo Hara, Takashi Kadowaki, Masato Odawara
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 8, 2014
Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes MellitusMasato Odawara, Izumi Hamada, Manabu Suzuki
Current Medical Research and Opinion|July 6, 2007
The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular riskJohn E Gerich, Masato Odawara, Yasuo Terauchi
Plos One|August 8, 2012
Potential formula for the calculation of starting and incremental insulin glargine doses: ALOHA subanalysisTakashi Kadowaki, Tetsuya Ohtani, Yusuke Naito, et al.
Pageof 9